The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.: 949100-10-1; N-methyl-1H-pyrazole-1-ethanamine trihydrochloride. PROPERTIES: This protonated amine salt features a methylated pyrazole ring connected to an ethylamine chain, creating a molecule with potential applications in medicinal chemistry and pharmaceutical research. The N-methyl-1H-pyrazole-1-ethanamine trihydrochloride typically appears as a white crystalline powder with high aqueous solubility due to its salt form. Its molecular structure includes a pyrazole ring that contributes to hydrogen bonding interactions and a methyl substituent that influences lipophilicity. For optimal stability and to preserve its crystalline form, this compound should be stored at 2-8 degree Celsius in a tightly sealed container under anhydrous conditions. When handling, appropriate safety measures including nitrile gloves and safety goggles are essential. This compound is hygroscopic and may absorb moisture from the atmosphere. In case of accidental spillage, clean the area with a damp cloth and dispose of materials according to local regulations. APPLICATIONS: The N-methyl-1H-pyrazole-1-ethanamine trihydrochloride serves as a valuable intermediate in the synthesis of pharmaceuticals, particularly those targeting the central nervous system. The pyrazole ring provides a platform for developing receptor modulators with specific binding profiles. In medicinal chemistry, this compound functions as a building block for creating antidepressant and anxiolytic agents where the pyrazole scaffold contributes to target engagement. Additionally, the molecule finds utility in chemical biology studies where its amine functionality can be further modified for bioconjugation applications. Researchers utilizing this compound benefit from its defined stereochemistry and functional group arrangement, advancing investigations into novel therapeutic approaches for neuropsychiatric conditions.